|
SIDLEY AUSTIN LLP 555 CALIFORNIA STREET SUITE 2000 SAN FRANCISCO, CA 94104 +1 415 772 1200 +1 415 772 7400 FAX
AMERICA ASIA PACIFIC EUROPE |
September 9, 2020
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention: |
Suzanne Hayes | |
Jeff Gabor | ||
Sasha Parikh | ||
Tracey Houser | ||
Re: |
Outset Medical, Inc. | |
Registration Statement on Form S-1 | ||
Filed August 21, 2020 | ||
File No. 333-248225 |
Ladies and Gentlemen:
On behalf of our client, Outset Medical, Inc. (Outset or the Company), we submit this letter in response to comments from the staff (the Staff) of the Securities and Exchange Commission (the Commission) contained in its letter dated September 3, 2020 (the Comment Letter), relating to the above referenced Registration Statement on Form S-1 filed on August 21, 2020 (the Registration Statement). Concurrently with this letter, we are transmitting via EDGAR for filing with the Commission an amendment to the Registration Statement on Form S-1 (the Amendment No. 1). For the Staffs reference, we are also providing to the Staff by overnight delivery copies of this letter as well as both a clean copy of the Amendment No. 1 and a copy marked to show all changes from the version filed with the Commission on August 21, 2020.
In this letter, we have recited the comment from the Staff in italicized, bold type and have followed the comment with the Companys response in ordinary type. Except for the page references contained in the comments of the Staff, or as otherwise specifically indicated, page references herein correspond to the Amendment No. 1.
Registration Statement on Form S-1 filed August 21, 2020
15. Subsequent Events, page F-62
1. | Please disclose the specific date through which subsequent events were evaluated in accordance with ASC 855-10-50-1. |
Response: The Company respectfully acknowledges the Staffs comment and has revised the disclosure on page F-62 of Amendment No. 1 to address this comment.
Sidley Austin (CA) LLP is a Delaware limited liability partnership doing business as Sidley Austin LLP and practicing in affiliation with other Sidley Austin partnerships.
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
September 9, 2020
Page 2
* * * *
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
September 9, 2020
Page 3
If you have questions with respect to Amendment No. 1 or the response set forth above, please direct the questions to me at (415) 772-1276 or frahmani@sidley.com.
Sincerely,
/s/ Frank F. Rahmani
Frank F. Rahmani
Sidley Austin LLP
cc: | Leslie Trigg, President, Chief Executive Officer and Director |
John L. Brottem, General Counsel |
Rebecca Chambers, Chief Financial Officer |
Robert A. Ryan, Sidley Austin LLP |
Helen Theung, Sidley Austin LLP |
Nathan Ajiashvili, Latham & Watkins LLP |
Brian Cuneo, Latham & Watkins LLP |